Categories: India

AstraZeneca files US FDA application for HUTCHMED lung cancer drug combination

Sept 29 (Reuters) – HUTCHMED (China) said on Tuesday Anglo-Swedish drugmaker AstraZeneca had filed an application with the US Food and Drug Administration for approval of the ORPATHYS-TAGRISSO

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

Soccer-Barcelona finalise €300 million bond issue to complete Camp Nou renovations

BARCELONA, Nov 13 (Reuters) - Barcelona announced on Friday that they had finalised a €300…

3 minutes ago

BRIEF-Air Astana JSC Notes Detainment Of CEO Of Samruk-Kazyna

Nov 13 (Reuters) - Air Astana JSC: * AIR ASTANA JSC - STATEMENT REGARDING THE…

7 minutes ago

Hours-long Microsoft outage disrupts businesses, governments globally

Nov 13 (Reuters) - A more than 12-hour outage of Microsoft Outlook and Teams crippled…

8 minutes ago

Indian fintech firm Razorpay gets regulatory nod for IPO

BENGALURU, Nov 13 (Reuters) - Indian fintech firm Razorpay has received the market regulator's approval…

9 minutes ago

Florida State bids to get back on track vs. Texas A&M-Corpus Christi

Florida State came up short in its first real test of the season. The Seminoles…

14 minutes ago